Please sign in to follow a disease.
Women's cycle phase linked to mountain sickness risk
NCT ID NCT06499714
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether the phase of a woman's menstrual cycle affects her chances of getting acute mountain sickness (AMS) when traveling to high altitude. Researchers followed 91 healthy women as they spent two days at 3600 meters (about 11,800 feet). The goal was to see if cycle phase influences AMS symptoms like headache and nausea.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this study could help women plan high-altitude travel to reduce their risk of altitude sickness based on their menstrual cycle phase.
- What could go wrong
- This is an observational study, not a treatment trial. Results may not apply to women on hormonal contraceptives or with irregular cycles.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
91 people
The number who actually took part.
- Started
-
Jul 2024
- Finished
-
Aug 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Healthy, non-smoking, premenopausal women, age 18-44 years, without any disease and need of regular medication (including oral contraceptives).
- Ages
-
18 to 44 years
- Sex
-
Female participants only
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Healthy, non-smoking women, age 18-44 years, without any disease and need of regular medication (including oral contraceptives). * BMI \>18 kg/m2 and \<30 kg/m2 * Born, raised and currently living at altitudes \<1000 m * Written informed consent * Premenopausal, eumenorrheic cycle Exclusion Criteria: * Other types of contraceptives (hormonal intrauterine device, vaginal ring, subcutaneous injections or implants, among others) * Pregnancy or nursing * Anaemic (haemoglobin concentration \<10g/dl) * Any altitude trip \<4 weks before the study * Allergy to acetazolamide and other sulfonamides
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Acute mountain sickness are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
National Center for Cardiology and Internal Medicine
Bishkek, Bishkek, 720040, Kyrgyzstan
More trials for these conditions
Other studies related to the condition(s) this trial covers.